Certara stock.
If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.
Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Dr Feehery owns over 36,580 units of Certara stock worth over $42,522,670 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. Wallmine is a …Nov 10, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ... Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...
Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued.PBF | Complete PBF Energy Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Starting January 1, 2020, all regulatory transactions for Master Files prepared in the non-eCTD format must be sent via the Common Electronic Submission Gateway (CESG). We have seen a spike in these types of submissions. The CESG has been in operation at Health Canada since February 2014, and it provides a secure and prompt …
Certara stock ( CERT) appears to check all the boxes. Nominated by one of our lovely subscribers, the New Jerzee-based company serves the drug development industry by offering software and services around its biosimulation platform. It claims to compete indirectly with companies like Schrödinger ( SDGR ), which uses a …Nov 17, 2021 · November 17, 2021. PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share. Open $0.9454. Day Range 0.9230 - 1.0100. 52 Week Range 0.7078 - 1.6300. Market Cap $454.63M. Shares Outstanding 399.78M. Public Float 370.52M. Beta 1.69. Rev. per Employee $3.692M. P/E Ratio N/A.Find the latest Telos Corporation (TLS) stock quote, history, news and other vital information to help you with your stock trading and investing.Certara Stock Performance NASDAQ CERT opened at $14.64 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.51 and a quick ratio of 3.51.
Latest Software and Certara Inc, UiPath Inc Stock News. As of November 30, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $404.5 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 9.83% in the past year. Currently, Certara Inc does not have a price-earnings ...
Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.
Certara Inc. 1699 South Hanley Road. St. Louis, Missouri 63144-2319. Phone 314 647-1099. Industry Software. Sector Technology. Fiscal Year-end N/A. Revenue.Dec 1, 2023 · 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price. Certara. Business Services · New Jersey, United States · 1,150 Employees. Certara is a drug development company that provides services and software that spans the drug development cycle from discovery to access. Certara is headquartered in Princeton, NJ with many locations across the globe. Read More. View Company Info for FreeThe estimated Net Worth of Leif E Pedersen is at least $5.76 million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $2,900,831 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Nov 9, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Real time Certara (CERT) stock price quote, stock graph, news & analysis.The estimated Net Worth of Leif E Pedersen is at least $5.68 Million dollars as of 22 November 2022. Mr Pedersen owns over 51,223 units of Certara stock worth over $2,820,285 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...View Certara, Inc CERT investment & stock information. Get the latest Certara, Inc CERT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
The estimated Net Worth of William F Feehery is at least $78.7 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.5 brokerages have issued 1-year price objectives for Elanco Animal Health's stock. Their ELAN share price targets range from $9.50 to $16.00. On average, they anticipate the company's share price to reach …Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday …Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ... 21 Seconds 22 -40% on all our subscriptions* Exceptional extension! Enjoy this offer * See conditions on site Financials (USD) More Fundamentals * Assessed data …Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.Follow. PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in ...Ms Sherman CERT stock SEC Form 4 insiders trading. Ms has made over 1 trades of the Certara stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 3,990 units of CERT stock worth $50,194 on 31 March 2023.. The largest trade she's ever made was exercising 3,990 units of Certara stock on 31 March …
Nov 21, 2023 · PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...
Mar 22, 2023 · Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55.
PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public …Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 5.27 M Change from Last -18.62% Percent of Float 4.84% Research & Ratings Certara Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range Consensus More View the latest Certara Inc....Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...Certara Inc Follow Share $14.64 After Hours: $14.64 (0.00%) 0.00 Closed: Dec 1, 4:03:07 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Exscientia PLC $6.17 EXAI1.15% Amazon.com Inc... Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%.Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Certara Inc. stock grades by Barron's. ... Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.Exhibit 10.21 . CERTARA, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN . 1. Purpose.The purpose of the Plan is to provide a means by which Eligible Employees may purchase Common Stock, thereby strengthening their commitment to the welfare of the Company and its Designated Companies and aligning their interests with those of the …Sep 13, 2023 · With a price of $14.6 and a GuruFocus Value of $25.18, the stock has a price-to-GF-Value ratio of 0.58. Story continues Despite the insider's recent sell, the undervaluation of Certara Inc's stock ... Instagram:https://instagram. tesla fadbest books for effective communicationbanks that give you a card the same day10000dollar bill Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ... sofi solar loanssite d'investissement en ligne fiable Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile. Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screens next amazon Certara recently reported its Q4 2022 financial results, beating revenue and EPS consensus estimates. Read more to know why I rate CERT stock as a hold.The estimated Net Worth of William F Feehery is at least $59.7 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $26,562,949 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.